Market Place
Sourcing Support
Eledon Updates Islet Transplant Trial Data For Tegoprubart
16 Mar 2026 //
GLOBENEWSWIRE
Eledon Pharma Joins Guggenheim Biotech Summit 2026
05 Feb 2026 //
GLOBENEWSWIRE
Eledon Pharma Shares Tegoprubart Data on Kidney Transplants
23 Jan 2026 //
GLOBENEWSWIRE
Eledon Unveils Tegoprubart Phase 2 Trial Results At Asn Kidney
06 Nov 2025 //
GLOBENEWSWIRE
Eledon Pharma To Present at Guggenheim Healthcare Innovation Conf
05 Nov 2025 //
GLOBENEWSWIRE
Eledon Pharma To Unveil Tegoprubart Phase 2 Trial Results At ASN
17 Oct 2025 //
GLOBENEWSWIRE
Eledon Pharmaceuticals to Attend Cantor Global Health Conference
29 Aug 2025 //
GLOBENEWSWIRE
Eledon Updates Phase 1b Trial Data on Tegoprubart for Kidney
06 Aug 2025 //
GLOBENEWSWIRE
Eledon Pharmaceuticals to Present Tegoprubart Phase 1b Trial
17 Jul 2025 //
GLOBENEWSWIRE
Sernova, Eledon Collaborate for Potential Type 1 Diabetes Cure
09 Jul 2025 //
GLOBENEWSWIRE
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in NYC
25 Jun 2025 //
GLOBENEWSWIRE
Eledon Pharmaceuticals at Leerink Partners Healthcare Conf.
04 Mar 2025 //
GLOBENEWSWIRE
Eledon Pharma Announces Tegoprubart in Pig Kidney Transplant
07 Feb 2025 //
GLOBENEWSWIRE
Eledon Pharma to Participate in Guggenheim Cap Biotech Conference
29 Jan 2025 //
GLOBENEWSWIRE
Eledon Pharma to Attend Guggenheim Healthcare Conferenc
06 Nov 2024 //
GLOBENEWSWIRE
Eledon Reports Positive Data on Tegoprubart in Type 1 Diabetes
29 Oct 2024 //
GLOBENEWSWIRE
Eledon Prices $85 Million Offering of Common Stock and Warrants
29 Oct 2024 //
GLOBENEWSWIRE
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
11 Sep 2024 //
GLOBENEWSWIRE
Eledon Completes Enrollment In Tegoprubart BESTOW Trial
04 Sep 2024 //
GLOBENEWSWIRE
Eledon`s Tegoprubart Kidney Transplant Prevention Phase 1b Update
03 Jun 2024 //
GLOBENEWSWIRE
Eledon Kidney Transplant Tegoprubart Data At Transplant Congress
09 May 2024 //
GLOBENEWSWIRE
Eledon Announces Tegoprubart in First-ever Transplant from a Pig to a Human
21 Mar 2024 //
GLOBENEWSWIRE
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart
02 Nov 2023 //
GLOBENEWSWIRE
Eledon Pharmaceuticals to Present Data from Phase 1b Trial of Tegoprubart
13 Oct 2023 //
GLOBENEWSWIRE
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody
25 Sep 2023 //
GLOBENEWSWIRE
Eledon Announces Publication of Data Showing Treatment with Tegoprubart
06 Sep 2023 //
GLOBENEWSWIRE
Eledon Announces First Participant Dosed in Phase 2 Trial Evaluating Tegoprubart
05 Sep 2023 //
GLOBENEWSWIRE
Eledon Announces Dosing of 10th Patient in Phase 1b Trial Evaluating Tegoprubart
16 Aug 2023 //
GLOBENEWSWIRE
Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart
31 Mar 2023 //
GLOBENEWSWIRE
Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart
23 Mar 2023 //
GLOBENEWSWIRE
eGenesis and Eledon Announce Collaboration for Use of Tegoprubart
09 Jan 2023 //
GLOBENEWSWIRE
